Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Iminosugar antivirals: the therapeutic sweet spot.
Alonzi DS, Scott KA, Dwek RA, Zitzmann N. Alonzi DS, et al. Biochem Soc Trans. 2017 Apr 15;45(2):571-582. doi: 10.1042/BST20160182. Biochem Soc Trans. 2017. PMID: 28408497 Free PMC article. Review.
Urinary glycan markers for disease.
Alonzi DS, Su YH, Butters TD. Alonzi DS, et al. Biochem Soc Trans. 2011 Jan;39(1):393-8. doi: 10.1042/BST0390393. Biochem Soc Trans. 2011. PMID: 21265811 Review.
An iminosugar with potent inhibition of dengue virus infection in vivo.
Perry ST, Buck MD, Plummer EM, Penmasta RA, Batra H, Stavale EJ, Warfield KL, Dwek RA, Butters TD, Alonzi DS, Lada SM, King K, Klose B, Ramstedt U, Shresta S. Perry ST, et al. Among authors: alonzi ds. Antiviral Res. 2013 Apr;98(1):35-43. doi: 10.1016/j.antiviral.2013.01.004. Epub 2013 Jan 31. Antiviral Res. 2013. PMID: 23376501
Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
Howe JD, Smith N, Lee MJ, Ardes-Guisot N, Vauzeilles B, Désiré J, Baron A, Blériot Y, Sollogoub M, Alonzi DS, Butters TD. Howe JD, et al. Among authors: alonzi ds. Bioorg Med Chem. 2013 Aug 15;21(16):4831-8. doi: 10.1016/j.bmc.2013.03.014. Epub 2013 Mar 22. Bioorg Med Chem. 2013. PMID: 23582447
Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.
Ersek A, Xu K, Antonopoulos A, Butters TD, Santo AE, Vattakuzhi Y, Williams LM, Goudevenou K, Danks L, Freidin A, Spanoudakis E, Parry S, Papaioannou M, Hatjiharissi E, Chaidos A, Alonzi DS, Twigg G, Hu M, Dwek RA, Haslam SM, Roberts I, Dell A, Rahemtulla A, Horwood NJ, Karadimitris A. Ersek A, et al. Among authors: alonzi ds. J Clin Invest. 2015 Jun;125(6):2279-92. doi: 10.1172/JCI59987. Epub 2015 Apr 27. J Clin Invest. 2015. PMID: 25915583 Free PMC article.
46 results